We are pleased to announce that our Director of Radiopharmaceuticals, Dr Wing Kwong Sidney Yu, has been admitted as a Fellow of the Institute of Biomedical Science (FIBMS), effective 01 January 2026. ama_clientAdmin December 16, 2025 Read More
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic ama_clientAdmin July 13, 2024 Read More